SYSTEMATIC REVIEW OF PERIPHERAL NERVE BLOCKS FOR POSTOPERATIVE PAIN MANAGEMENT
Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.
Award details
- Award ID
- 75Q80124F32011
- Contractor
- REGENTS OF THE UNIVERSITY OF MINNESOTA
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- Agency for Healthcare Research and Quality
- Award amount
- $557,000
- Period of performance
- Dec 8, 2023 – Dec 27, 2024
- Place of performance
- PORTLAND, OR, 972271110, USA
- Competition
- FULL AND OPEN COMPETITION · 1 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $1,455,500 · Obligated $1,455,500 · Potential value $1,455,500 · Latest action obligation $1,455,500 · Outlays $1,337,000
- Parent award
- 75Q80120D00004
Public award description
SYSTEMATIC REVIEW OF PERIPHERAL NERVE BLOCKS FOR POSTOPERATIVE PAIN MANAGEMENT
Related intelligence
- Contractor: REGENTS OF THE UNIVERSITY OF MINNESOTA
- Agency: Department of Health and Human Services
- Federal market intelligence software
Related Federal Awards
- · W900KK24C0041 — GRID OF POWERFUL HPC ENGINEERING RESOURCES AND SYSTEMS (GOPHERS) · REGENTS OF THE UNIVERSITY OF MINNESOTA · Department of Defense · $10,232,265
- · 75FCMC25FJ140 — THE PURPOSE OF THIS CONTRACT IS TO) PROVIDES ASSISTANCE TO RESEARCHERS NATIONWIDE WHO MAY OR MAY NOT BE FAM… · REGENTS OF THE UNIVERSITY OF MINNESOTA · Department of Health and Human Services · $3,179,328
- · W912HQ26CA054 — WP25-9775 REGENTS OF THE UNIVERSITY OF MINNESOTA ENTITLED DEMONSTRATION CENTER FOR CRITICAL MATERIAL RECAPT… · REGENTS OF THE UNIVERSITY OF MINNESOTA · Department of Defense · $2,215,954
- · 75N94026F00001 — NICHD: R&D: SPAN ANALYSIS 2026: NON-SEVERABLE · Department of Health and Human Services · $1,964,764
- · W912HQ24C0016 — STRATEGIC ENVIRONMENTAL RESEARCH AND DEVELOPMENT PROGRAM PROJECT RC23-3845. RNA INTERFERENCE - RNAI - FOR T… · REGENTS OF THE UNIVERSITY OF MINNESOTA · Department of Defense · $1,120,439
- · 75N94025F00002 — NICHD: R&D: METABOLOME OF SLEEP AND ADVERSE BIRTH OUTCOMES: NON-SEVERABLE · Department of Health and Human Services · $916,859